Harvard Bioscience (HBIO) Enterprise Value (2010 - 2026)
Harvard Bioscience (HBIO) reported Enterprise Value of -$7.1 million for Q1 2026, down 27.98% year-over-year from -$9.9 million in Q1 2025, and up 17.6% quarter-over-quarter from -$8.6 million in Q4 2025.
Harvard Bioscience (HBIO) Enterprise Value (2010 - 2026) Analysis & Trends
Harvard Bioscience (HBIO) has 17 years of Enterprise Value data on file, last reported at -$7.1 million in Q1 2026.
- Enterprise Value for Q1 2026 came in at -$7.1 million, down 27.98% year-over-year; the trailing twelve-month figure through Mar 2026 was -$7.1 million (down 27.98% YoY), and the FY2025 annual result was -$8.6 million, down 109.69% from the prior year.
- Enterprise Value climbed to -$7.1 million in Q1 2026 per HBIO's latest filing, from -$8.6 million in the prior quarter.
- Over five years, Enterprise Value peaked at -$3.8 million in Q1 2023 and troughed at -$8.6 million in Q4 2025.
- A 5-year average of -$5.3 million and a median of -$4.6 million in 2024 frame the typical range for Enterprise Value.
- The sharpest annual moves came in 2022 and 2025: Enterprise Value surged 42.36% in 2022, then plunged 109.69% in 2025.
- A 5-year view of Enterprise Value shows it stood at -$4.5 million in 2022, then increased by 4.99% to -$4.3 million in 2023, then grew by 4.09% to -$4.1 million in 2024, then sank by 109.69% to -$8.6 million in 2025, then gained by 17.6% to -$7.1 million in 2026.
- Business Quant data shows HBIO's Enterprise Value at -$7.1 million in Q1 2026, -$8.6 million in Q4 2025, and -$6.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | -4.39 Bn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | -1.02 Bn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 5.84 Bn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | -1.66 Bn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | -521.40 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | -561.00 Mn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | -138.60 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | -1.06 Bn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | -2.05 Bn |
| 10 | Harvard Bioscience | 26.17 Mn | 19.07 Mn | 12.24 Mn | -7.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -7.10 Mn |
| Dec 31, 2025 | -8.61 Mn |
| Sep 30, 2025 | -6.82 Mn |
| Jun 30, 2025 | -7.44 Mn |
| Mar 31, 2025 | -5.55 Mn |
| Dec 31, 2024 | -4.11 Mn |
| Sep 30, 2024 | -4.57 Mn |
| Jun 30, 2024 | -4.08 Mn |
| Mar 31, 2024 | -4.26 Mn |
| Dec 31, 2023 | -4.28 Mn |
| Sep 30, 2023 | -5.34 Mn |
| Jun 30, 2023 | -4.32 Mn |
| Mar 31, 2023 | -3.79 Mn |
| Dec 31, 2022 | -4.51 Mn |
| Sep 30, 2022 | -5.14 Mn |
| Jun 30, 2022 | -4.26 Mn |
| Mar 31, 2022 | -5.43 Mn |
| Dec 31, 2021 | -7.82 Mn |
| Sep 30, 2021 | -5.55 Mn |
| Jun 30, 2021 | -6.24 Mn |